國立高雄大學圖資館 |

Language: English

Back

Cell therapycGMP facilities and manufacturing /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cell therapyedited by Adrian P. Gee.
Reminder of title:	cGMP facilities and manufacturing /
other author:	Gee, Adrian P.
Published:	Cham :Springer International Publishing :2022.
Description:	x, 692 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Cellular therapy.
Online resource:	https://doi.org/10.1007/978-3-030-75537-9
ISBN:	9783030755379$q(electronic bk.)

Cell therapycGMP facilities and manufacturing /
Cell therapy (Gee)

Cell therapycGMP facilities and manufacturing /[electronic resource] :edited by Adrian P. Gee. - Second edition. - Cham :Springer International Publishing :2022. - x, 692 p. :ill. (some col.), digital ;24 cm.

This new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banking, cell processing, vector production and qualification of a new facility. Several chapters cover facility infrastructure including cleaning and maintenance, vendor qualification, writing a Standard Operating Procedure, staff training, and process validation. The detailed and invaluable product information covers topics like labelling, release and administration, transportation and shipment, et al. Further chapters cover relevant topics like writing and maintaining investigational new drug applications, support opportunities in North America and the European Union, commercial cell processing and quality testing services, and financial considerations for academic GMP facilities. A chapter on future directions rounds out Cell Therapy: cGMP Facilities and Manufacturing making it essential reading for any cell therapy professional involved in the development, use, or management of this type of facility.

ISBN: 9783030755379$q(electronic bk.)

Standard No.: 10.1007/978-3-030-75537-9doiSubjects--Topical Terms:

201246
Cellular therapy.

LC Class. No.: RM301.37 / .C45 2022

Dewey Class. No.: 615.89

Cell therapycGMP facilities and manufacturing /
LDR:02172nmm a2200325 a 4500 001 617486
003 DE-He213
005 20211110132412.0
006 m d
007 cr nn 008maaau
008 221025s2022 sz s 0 eng d
020 $a 9783030755379$q(electronic bk.)
020 $a 9783030755355$q(paper)
024 7 $a 10.1007/978-3-030-75537-9 $2 doi
035 $a 978-3-030-75537-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.37 $b .C45 2022
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a PSF $2 thema
082 0 4 $a 615.89 $2 23
090 $a RM301.37 $b .C393 2022
130 0 $a Cell therapy (Gee) $3 916995
245 1 0 $a Cell therapy $h [electronic resource] : $b cGMP facilities and manufacturing / $c edited by Adrian P. Gee.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a x, 692 p. : $b ill. (some col.), digital ; $c 24 cm.
520 $a This new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banking, cell processing, vector production and qualification of a new facility. Several chapters cover facility infrastructure including cleaning and maintenance, vendor qualification, writing a Standard Operating Procedure, staff training, and process validation. The detailed and invaluable product information covers topics like labelling, release and administration, transportation and shipment, et al. Further chapters cover relevant topics like writing and maintaining investigational new drug applications, support opportunities in North America and the European Union, commercial cell processing and quality testing services, and financial considerations for academic GMP facilities. A chapter on future directions rounds out Cell Therapy: cGMP Facilities and Manufacturing making it essential reading for any cell therapy professional involved in the development, use, or management of this type of facility.
650 0 $a Cellular therapy. $3 201246
650 1 4 $a Cell Biology. $3 274165
650 2 4 $a Drug Safety and Pharmacovigilance. $3 701740
650 2 4 $a Facility Management. $3 273742
700 1 $a Gee, Adrian P. $3 916996
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-75537-9
950 $a Biomedical and Life Sciences (SpringerNature-11642)